In 2023, the European analgesic medicine market showed varied trends across different countries. Spain, with sales reaching 878.3 million Euros, experienced a modest growth of 3.22% year-on-year. Greece saw a decline of 4.42%, while Finland and Slovenia reported growths of 5.34% and 8.25%, respectively. Estonia marked the highest increase with 11.06%, despite having the smallest market size of 14.7 million Euros. Over the last five years, the compound annual growth trends have been positive, reflecting an increasing demand for analgesic medicines in Europe.
Future trends to watch include:
- Impact of aging population on the demand for pain relief medication.
- Increasing preference for non-opioid analgesics due to awareness of opioid risks.
- Regulatory changes affecting the availability and pricing of analgesic medications.
- Technological advances in drug delivery and personalized medicine.
Top countries in Analgesic Medicine Sales by Country
| # | 5 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 878.3 | 2023 | +2.49% | +3.22% | View data |
| 2 | 2 Greece | 118 | 2023 | +2.34% | -4.42% | View data |
| 3 | 3 Finland | 82.9 | 2023 | +0.85% | +5.34% | View data |
| 4 | 4 Slovenia | 27.2 | 2023 | +9.24% | +8.25% | View data |
| 5 | 5 Estonia | 14.7 | 2023 | +9.7% | +11.06% | View data |
